S. Chakrabarti

发表

Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia

D. Bevan, P. Anoop, S. Chakrabarti, 2009, American journal of hematology.

CTLA4Ig Primed Donor Lymphocyte Infusion: A Novel Approach to Immunotherapy after Haploidentical Transplantation for Advanced Leukemia.

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cancer in Fanconi Anemia

Sb, S. Chakrabarti, Perez-Simon, 2022 .

Rotavirus infection following post‐transplantation cyclophosphamide based haploidentical hematopoietic cell transplantation in children is associated with hemophagocytic syndrome and high mortality

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Immunohistochemical Characterization of Cell of Origin in Diffuse Large B-cell Lymphoma and its Correlation with the Double Expressor Phenotype: A Retrospective Study in a Tertiary Cancer Care Centre

S. Jaiswal, S. Chakrabarti, G. Sharma, 2021 .

Critical factors in optimizing graft-versus-leukemia effect for relapsed leukemias.

S. Chakrabarti, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Preemptive Granulocyte Infusions During Febrile Neutropenia in Patients Colonized with Carbapenem-Resistant Gram-Negative Bacteria Undergoing Haploidentical Transplantation.

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease

D. Bareford, S. Chakrabarti, 2007, Bone Marrow Transplantation.

Reduced-intensity transplantation in the treatment of haematological malignancies: current status and future-prospects.

S. Chakrabarti, H. Buyck, 2007, Current stem cell research & therapy.

Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2020, Annals of Hematology.

Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning

D. Milligan, S. Chakrabarti, H. Osman, 2003, Bone Marrow Transplantation.

Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.

C. Fegan, P. Moss, V. Mautner, 2002, Blood.

Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity.

T. Gentle, D. Milligan, G. Hale, 2001, Transplantation.

A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis

A. Barrett, D. Metcalfe, R. Childs, 2006, Bone Marrow Transplantation.

Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?

M. Griffiths, D. Milligan, S. Chakrabarti, 2001, Transplantation.

In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.

G. Morgan, S. Mackinnon, S. Verfuerth, 2001, Cytotherapy.

Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?

D. Bareford, S. Chakrabarti, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone

C. McConkey, D. Milligan, S. Chakrabarti, 2004, Bone Marrow Transplantation.

Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant

N. Russell, R. Chopra, G. Jackson, 2001, Bone Marrow Transplantation.

A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy.

S. Mackinnon, H. Waldmann, D. Linch, 1999 .

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.

D. Pillay, C. Fegan, S. Mackinnon, 2003, Blood.

Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens

D. Marks, D. Milligan, D. Pamphilon, 2004, Bone Marrow Transplantation.

Should we T cell deplete sibling grafts for acute myeloid leukaemia in first remission?

D. Marks, S. Chakrabarti, 2003, Bone Marrow Transplantation.

Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback

D. Marks, M. Guttridge, D. Pamphilon, 2003, Bone Marrow Transplantation.

T cell costimulation blockade for hyperacute steroid refractory graft versus-host disease in children undergoing haploidentical transplantation.

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2016, Transplant immunology.

Haploidentical Transplantation: Challenges and Solutions

S. Jaiswal, S. Chakrabarti, 2020, Contemporary Bone Marrow Transplantation.

Impact of an Immune Modulator Mycobacterium-w on Adaptive Natural Killer Cells and Protection Against COVID-19

S. Jaiswal, S. Chakrabarti, B. Khamar, 2021, Frontiers in Immunology.

Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure

D. Mitra, S. Jaiswal, P. Malhotra, 2020, Mediterranean journal of hematology and infectious diseases.

Viral disease prevention after hematopoietic cell transplantation

H. Einsele, M. Boeckh, P. Ljungman, 2009, Bone Marrow Transplantation.

When matched family donor is not available for blood and marrow transplantation—the Indian dilemma

S. Chakrabarti, 2012 .

Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease

A. Osterhaus, P. Cane, S. Chakrabarti, 2003, Bone Marrow Transplantation.

Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation

S. Mackinnon, D. Linch, A. Dogan, 2004, Bone Marrow Transplantation.

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

G. Morgan, S. Mackinnon, K. Peggs, 2000, Blood.

Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation

S. Jaiswal, S. Chakrabarti, M. Soni, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

P. Veys, S. Samarasinghe, P. Amrolia, 2007, Leukemia & lymphoma.

Safety and efficacy of Sofosbuvir and Velpatasvir in children with active hepatitis C virus infection undergoing haploidentical transplantation

S. Jaiswal, S. Chakrabarti, M. Soni, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.

C. Craddock, S. Mackinnon, K. Peggs, 2002, Blood.

Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning.

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Targeting CD28-CD86 Pathway for Refractory Myeloma Through CTLA4Ig-Based Reduced-Intensity Conditioning and Donor Lymphocyte Infusions After Haploidentical Transplantation.

S. Jaiswal, S. Chakrabarti, Prakash Bhakuni, 2019, Clinical lymphoma, myeloma & leukemia.

Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease

A. Bhardwaj, S. Jaiswal, S. Chakrabarti, 2022, Clinical & translational immunology.

Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease

A. Bhardwaj, J. Arunachalam, S. Jaiswal, 2021, medRxiv.

Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy

D. Milligan, S. Chakrabarti, K. Collingham, 1999, Bone Marrow Transplantation.

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab.

C. Fegan, S. Mackinnon, G. Hale, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Respiratory virus infections in transplant recipients after reduced‐intensity conditioning with Campath‐1H: high incidence but low mortality

C. Fegan, S. Mackinnon, G. Hale, 2002, British journal of haematology.

Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.

D. Pillay, D. Milligan, S. Chakrabarti, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

immunosuppression, and immune recovery incidence and outcome in relation to graft manipulation, Adenovirus infections following allogeneic stem cell transplantation:

C. Fegan, P. Moss, V. Mautner, 2013 .

Adenovirus Infections in Stem Cell Transplant Recipients: Recent Developments in Understanding of Pathogenesis, Diagnosis and Management

P. Moss, V. Mautner, D. Milligan, 2004, Leukemia & lymphoma.

Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study

D. Pillay, D. Milligan, S. Chakrabarti, 2000, Bone Marrow Transplantation.

Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study

S. Jaiswal, S. Chakrabarti, R. Kumar, 2018, Mediterranean journal of hematology and infectious diseases.

Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?

D. Pillay, C. Fegan, D. Milligan, 2000, Bone Marrow Transplantation.

An unusual cause of acute abdomen following allogeneic transplantation: a zoonotic disease revisited

S. Grubnic, S. Chakrabarti, R. Holliman, 2008, Bone Marrow Transplantation.

Adenovirus infections after hematopoietic stem cell transplantation: still unravelling the story.

S. Chakrabarti, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease Comparison with a busulphan-cyclophosphamide regimen

P. Lähteenmäki, J. Cornish, A. Oakhill, 2004, Acta oncologica.

Alterations in NKG2A and NKG2C Subsets of Natural Killer Cells Following Epstein–Barr Virus Reactivation in CTLA4Ig-based Haploidentical Transplantation Is Associated With Increased Chronic Graft-Versus-Host Disease

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2020, Transplantation.

Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia

S. Ball, S. Chakrabarti, J. Marsh, 2009, Bone Marrow Transplantation.

Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?

G. Hale, H. Waldmann, S. Chakrabarti, 2004, Transplantation proceedings.

T‐cell depletion with Campath‐1H ‘in the bag’ for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft‐versus‐host disease, rapid immune constitution and improved survival

C. Fegan, G. Hale, H. Waldmann, 2003, British journal of haematology.

Early and Sustained Expansion of Adaptive Natural Killer Cells Following Haploidentical Transplantation and CTLA4Ig-Primed Donor Lymphocyte Infusions Dissociate Graft-versus-Leukemia and Graft-versus-Host Effects.

S. Jaiswal, S. Chakrabarti, M. Soni, 2021, Transplantation and cellular therapy.

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study

C. Fegan, D. Milligan, D. Milligan, 2001, Bone Marrow Transplantation.

Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance.

D. Pillay, P. Cane, D. Milligan, 2000, The Journal of infectious diseases.

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

C. Craddock, C. Fegan, S. Mackinnon, 2002, Blood.

Limiting the Impact of Methicillin-Resistant Staphylococcus Aureus in Patients Undergoing Haploidentical Transplantation

S. Jaiswal, S. Chakrabarti, H. Aiyer, 2020, Mediterranean journal of hematology and infectious diseases.

Prevention and Treatment of Hepatitis Virus Infections in Hematopoietic Stem Cell Transplant Recipients

S. Chakrabarti, S. Mukherjee, 2009, Mediterranean journal of hematology and infectious diseases.

Prevention and Treatment of Hepatitis Cell Transplant Recipients

S. Chakrabarti, S. Mukherjee, M. Chakrabarti, 2009 .

CTLA4Ig-primed donor lymphocyte infusions following haploidentical transplantation improve outcome with a distinct pattern of early immune reconstitution as compared to conventional donor lymphocyte infusions in advanced hematological malignancies

Rishabh Raj Jaiswal, S. Jaiswal, S. Chakrabarti, 2020, Bone Marrow Transplantation.

CTLA4Ig Limits Both Incidence and Severity Of Early Cytokine Release Syndrome Following Haploidentical Peripheral Blood Stem Cell Transplantation.

S. Jaiswal, S. Chakrabarti, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Natural killer cell-based immunotherapy with CTLA4Ig-primed donor lymphocytes following haploidentical transplantation.

S. Jaiswal, S. Chakrabarti, 2019, Immunotherapy.

CTLA4Ig Based Reduced Intensity Conditioning and Donor Lymphocyte Infusions For Haploidentical Transplantation In Refractory Aggressive B Cell Lymphoma Relapsing after An Autograft: Early Results From A Pilot Study.

S. Jaiswal, S. Chakrabarti, H. Aiyer, 2019, Experimental hematology.

Allogeneic Hematopoietic Stem Cell Transplantation for Myeloma: Time for an Obituary or Not Just Yet!

S. Jaiswal, S. Chakrabarti, 2019, Indian Journal of Hematology and Blood Transfusion.

CTLA4Ig In An Extended Schedule Along With Sirolimus Improves Outcome With A Distinct Pattern of Immune Reconstitution Following Post-Transplantation Cyclophosphamide Based Haploidentical Transplantation For Hemoglobinopathies.

S. Jaiswal, S. Chakrabarti, M. Soni, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher CD45RA+ Regulatory T Cells in the Graft Improves Outcome in Younger Patients Undergoing T Cell-Replete Haploidentical Transplantation: Where Donor Age Matters.

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease:

S. Jaiswal, S. Rawat, S. Chakrabarti, 2017, Cytotherapy.

Enterovirus infections following T-cell depleted allogeneic transplants in adults

C. Fegan, D. Milligan, D. Milligan, 2004, Bone Marrow Transplantation.

Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved Issues

S. Jaiswal, S. Chakrabarti, 2016, Advances in hematology.

Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2016, International Journal of Hematology.

Haploidentical transplantation in children with unmanipulated peripheral blood stem cell graft: The need to look beyond post‐transplantation cyclophosphamide in younger children

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2016, Pediatric transplantation.

Pre-transplant sirolimus might improve the outcome of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide for patients with severe aplastic anemia

S. Jaiswal, S. Chakrabarti, S. Mukherjee, 2015, Bone Marrow Transplantation.

Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor-Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Compar

S. Jaiswal, S. Chakrabarti, Prakash Bhakuni, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T cell-depleted nonmyeloablative stem cell transplantation: what is the optimum balance between the intensity of host conditioning and the degree of T cell depletion of the graft?

D. Milligan, S. Chakrabarti, D. Mcdonald, 2001, Bone Marrow Transplantation.

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia?

S. Chakrabarti, Surjit Singh, Subhash Varma, 1998, European journal of haematology.

Paternal bone marrow infusion as salvage therapy for severe GVHD following maternal haploidentical transplantation resulting in biparental chimerism

S. Jaiswal, S. Chakrabarti, S. Chatterjee, 2013, International Journal of Hematology.

The place of rituximab in the treatment algorithm for post-stem cell transplant autoimmune hemolytic anemia.

S. Chakrabarti, 2002, Haematologica.

Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anaemia in Children and Young Adults: A Report from the Pediatric...

R. Uppuluri, Revathi Raj, S. Jaiswal, 2022, Transplantation and cellular therapy.

Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality

D. Milligan, S. Chakrabarti, S. Jones, 2000, Bone Marrow Transplantation.

T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia.

S. Jaiswal, S. Chakrabarti, Shamsuz Zaman, 2017, Transplant immunology.

Increased CMV infection following nonmyeloablative allogeneic stem cell transplantation: a search for the guilty.

S. Chakrabarti, 2003, Blood.

Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions.

S. Jaiswal, S. Mukherjee, S. Chakrabarti, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical hematopoietic cell transplantation: Current status and future prospects

S. Jaiswal, S. Chakrabarti, 2020 .

CTLA4Ig-based T-cell costimulation blockade is associated with reduction of adenovirus viremia following post-transplantation cyclophosphamide-based haploidentical transplantation

S. Jaiswal, S. Chakrabarti, Aditi Chakrabarti, 2019, Bone Marrow Transplantation.

Early Expansion of CD56dim NKG2Alow with Late Surge and Persistence of CD56dimNKG2AnegNKG2Cbright NK Cells Attenuate Cytomegalovirus (CMV) Replication and Recurrence As Well As Leukemia Relapse Following Haploidentical HSCT with T Cell Co-Stimulation Blockade and Ptcy

S. Jaiswal, S. Chakrabarti, Prakash Bhakuni, 2019, Biology of Blood and Marrow Transplantation.

The relevance of nonmyeloablative transplants in developing countries: lessons from the UK experience.

S. Mackinnon, S. Chakrabarti, 2003, Transplantation proceedings.

Gut Colonization with Carbapenem Resistant Enterobactriaceae (CRE) Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of a Prospective Surveillance Study

S. Jaiswal, S. Chakrabarti, Satyanker Gupta, 2016 .

Allogeneic Hematopoietic Stem Cell Transplantation at Fifty : Is it Facing an Existential Crisis in the Midst of Newer Innovations in the Field of Hematological Malignancies !

S. Jaiswal, S. Chakrabarti, 2019 .

Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections

D. Milligan, S. Chakrabarti, H. Osman, 2001, Bone Marrow Transplantation.

Non-herpes virus infections after stem cell transplantation and anti-viral immunity.

S. Chakrabarti, 2003, Transplantation proceedings.

Abatacept and T-cell costimulation blockade—shifting the paradigm in the prevention of graft-versus-host disease

S. Jaiswal, S. Chakrabarti, 2023, Frontiers in Hematology.

Long-Term Outcome of Abatacept-Ptcy-Sirolimus Based Haploidentical HCT in Younger Patients with Nonmalignant Diseases

S. Jaiswal, S. Chakrabarti, S. Biswas, 2023, Transplantation and Cellular Therapy.

Immunogenetic Determinants of Relapse and Non-Relapse Mortality Following Haploidentical HCT with Ptcy and T Cell Costimulation Blockade with Abatacept

S. Jaiswal, S. Chakrabarti, S. Biswas, 2023, Transplantation and Cellular Therapy.

S. Jaiswal, S. Chakrabarti, Prakash Bhakuni, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Developing a Haploidentical Transplant Program: An Indian Experience

S. Jaiswal, S. Chakrabarti, K. Sharma, 2015 .

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.

C. Craddock, S. Mackinnon, K. Peggs, 2002, Blood.